U.S. FDA clears additional lots of Moderna's Covid booster amid shortage




  • In Health
  • 2022-09-26 21:19:03Z
  • By Reuters
 

(Reuters) - The U.S. Food and Drug Administration said on Monday it has authorized an additional five batches of Moderna Inc's updated Covid booster shots made at a Catalent facility in Indiana, after it deemed them safe for use.

Last week, the health regulator had allowed use of ten batches of Moderna's updated booster shots made at the Bloomington, Indiana facility, owned by a unit of Catalent Inc, which is currently not a part of the company's emergency use authorization.

The FDA had earlier said Moderna had requested authorization for additional batches in light of the current supply issues. It did not provide details on the number of doses cleared in both instances.

U.S. pharmacy chains like CVS Health and Walgreens Boots Alliance have been working with the U.S. government to acquire more Moderna doses and said they have not seen any supply issues for the Pfizer/BioNtech booster shot.

The U.S. government, which has sent out over 25 million of the COVID-19 booster shots targeting BA.4 and BA.5 subvariants of Omicron, has ordered more than 170 million updated shots for this fall, in preparation for a broad revaccination campaign.

(Reporting by Bhanvi Satija in Bengaluru; Editing by Krishna Chandra Eluri)

COMMENTS

More Related News

Pfizer, BioNTech countersue Moderna over COVID-19 vaccine patents
Pfizer, BioNTech countersue Moderna over COVID-19 vaccine patents

(Reuters) -Pfizer Inc and its German partner, BioNTech SE, fired back at Moderna Inc on Monday in a patent lawsuit over their rival COVID-19 vaccines, seeking dismissal of the lawsuit in Boston federal court and an order that Moderna's patents are invalid and not infringed. Moderna first sued Pfizer in August, accusing the company of violating its rights in three patents related to innovations that Cambridge, Massachusetts-based Moderna said it pioneered before the COVID-19 pandemic. Moderna has also filed a related lawsuit against Pfizer and BioNTech in Germany.

Pfizer asks FDA to clear updated COVID shot for kids under 5
Pfizer asks FDA to clear updated COVID shot for kids under 5
  • US
  • 2022-12-05 15:49:17Z

Pfizer is asking U.S. regulators to authorize its updated COVID-19 vaccine for children under age 5 - not as a booster but part of their initial shots. Children ages 6 months through 4 years already are supposed to get three extra-small doses of the original Pfizer COVID-19 vaccine - each a tenth of the amount adults receive - as their primary series. If the Food and Drug Administration agrees, a dose of Pfizer's bivalent omicron-targeting vaccine would be substituted for their third shot.

Pfizer applies for FDA authorization for Omicron-retooled vaccine booster in kids under 5
Pfizer applies for FDA authorization for Omicron-retooled vaccine booster in kids under 5
  • US
  • 2022-12-05 12:02:10Z

If authorized, children would receive the primary series consisting of two doses of the original Pfizer-BioNTech COVID vaccine and one shot of the Omicron...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Health